Testing effectiveness (Phase 2)UnknownNCT05420285
What this trial is testing
Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction
Who this might be right for
Heart FailureReduced Ejection Fraction
Assistance Publique - Hôpitaux de Paris 40